ATON 0.017 € (+1,20 %)
LIGHTON 3.860 € (+0,39 %)
EMEIS 15.050 € (-1,83 %)
LOUIS HACHETTE 1.573 € (-0,38 %)
ONE EXPERIENCE 0.374 € (-5,08 %)
PLANISWARE 17.040 € (+0,24 %)
STELLANTIS NV 6.424 € (-4,11 %)
VEOLIA ENVIRON. 33.780 € (-2,54 %)
CELLECTIS 3.644 € (+2,07 %)
ASML HOLDING 1 301.600 € (-4,78 %)
X-FAB 8.030 € (+3,41 %)
ALTEN 61.250 € (+0,25 %)
ASM INTERNATIONAL 856.800 € (-4,78 %)
VALEO 12.565 € (-2,10 %)
AIR LIQUIDE 177.040 € (-1,07 %)
VALLOUREC 26.740 € (-2,19 %)
LVMH 455.100 € (-1,25 %)
STMICROELECTRONICS 52.420 € (-4,97 %)
ADYEN 892.100 € (-0,66 %)
ARCELORMITTAL SA 52.340 € (-4,84 %)
EUROFINS SCIENT. 59.080 € (-0,54 %)
CAPGEMINI 99.200 € (+2,59 %)
PUBLICIS GROUPE SA 77.240 € (-0,49 %)
SANOFI 74.240 € (+1,37 %)
KERING 238.300 € (-2,48 %)
RELX 27.820 € (+1,68 %)
SAINT GOBAIN 74.820 € (-2,32 %)
SCOR SE 31.900 € (+1,21 %)
ABIVAX 100.000 € (-3,38 %)
IMPRESA,SGPS 0.178 € (-1,00 %)
MAGNUM 14.360 € (+10,39 %)
EDP 4.263 € (-3,11 %)
Vusion 121.100 € (-2,50 %)
VALBIOTIS 1.108 € (-8,58 %)
SOITEC 144.250 € (-5,04 %)
EXOSENS 58.150 € (+0,61 %)
L'OREAL 356.950 € (-0,54 %)
OSE IMMUNO 5.640 € (+14,40 %)
SPIE 47.820 € (-1,36 %)
EUTELSAT COMMUNIC. 2.828 € (-6,26 %)
WENDEL 87.700 € (-0,90 %)
SAFRAN 272.900 € (-3,64 %)
SOCIETE GENERALE 66.270 € (-1,76 %)
UMG 20.510 € (+2,40 %)
CASINO GUICHARD 0.225 € (-2,51 %)
LEGRAND 152.100 € (-1,68 %)
ING GROEP N.V. 25.400 € (-2,10 %)
IBERSOL,SGPS 11.660 € (-0,68 %)
NN GROUP 75.980 € (-0,31 %)
CREDIT AGRICOLE 16.855 € (-1,83 %)
BNP PARIBAS ACT.A 88.890 € (-3,41 %)
DRONE VOLT 0.452 € (-5,79 %)
SCHNEIDER ELECTRIC 263.500 € (-2,75 %)
KALRAY 8.390 € (-9,78 %)
SES 7.630 € (-5,80 %)
AIRBUS 168.540 € (-2,43 %)
CSG 16.312 € (+0,69 %)
TOTALENERGIES 78.750 € (+0,60 %)
CARREFOUR 17.155 € (-0,17 %)
PROSUS 39.195 € (+1,23 %) |
15/05/2026 09:05
Ring-type Blood Pressure Monitor 'CART' Completes UK MHRA Medical Device Approval, Establishing Foundation for Entry into the UK Following EuropeEQS-News: Sky Labs / Key word(s): Expansion
SEOUL, South Korea, May 15, 2026 /PRNewswire/ -- Sky Labs' ring-type blood pressure monitor 'CART' has prepared the footing for its entry into the UK market, following its expansion into Europe. ![]() Sky Labs (CEO Jack Byunghwan Lee) announced on the 15th that its ring-type blood pressure monitoring platform, CART PLATFORM, has officially completed medical device registration and received marketing authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA is a government agency responsible for regulating the safety, quality, and efficacy of all medicines and medical devices. Following its acquisition of the European Medical Device Regulation (CE-MDR) certification in January, Sky Labs has now solidified its foundation for entering the UK market by completing the MHRA registration and approval process. The CART PLATFORM is a product that integrates a ring-type wearable device, a mobile app, a server and a web viewer for medical professionals. As the entire platform—from hardware to software—has passed the certification, Sky Labs plans to launch full-scale sales through prescriptions at pharmacies, hospitals, and clinics in the UK market. Sky Labs' ring-type wearable blood pressure monitor, 'CART BP pro', has already established a dominant presence in its home market. In addition to approval from the Ministry of Food and Drug Safety (MFDS)—South Korea's national regulatory authority equivalent to the U.S. FDA—the device has been integrated into clinical practice at approximately 1,800 hospitals and clinics nationwide since obtaining medical service reimbursement in 2024. This signifies that the product has proven not only its technological prowess and safety but also its acceptability within the health insurance system. Jack Byunghwan Lee, CEO of Sky Labs, said, "In a system centered on cuff-type blood pressure monitors that has been maintained for hundreds of years, the fact that the world's only cuffless ring-type blood pressure monitor has received medical device authorization from international regulatory agencies proves that Sky Labs' technology and clinical maturity have been recognized by global standards." He added, "This shows that a new paradigm in blood pressure management, which simultaneously satisfies the clinical efficiency of medical staff and the measurement convenience of patients, is becoming a reality." About Sky Labs https://skylabs.io/en/ Media Inquiries ![]() Photo - https://mma.prnewswire.com/media/2980830/image1.jpg
![]() 15.05.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. 2327938 15.05.2026 CET/CEST Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière


